Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Clinical trial NCT07062354 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07062354
- Sponsor
- SWOG Cancer Research Network
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2028-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.